Psychiatric Side Effects of Tricyclic Antidepressants
Abstract
Psychiatric toxicity to tnicycic antidepressants may be an underrecognized adverse effect of treatment with tricyclics, possibly occurring in between 5 and 15 percent of patients. Such toxicity is probably mediated by a central antimuscarinic action of the tricyclics and is associated with elevated plasma tricyclic levels, age, polypharmacy, and perhaps underlying cholinergic defects in susceptible individuals. Once tricyclic-induced toxicity is recognized, the treatment consists of discontinuing the tricyclic and providing supportive care as necessary. Many cases of tricyclic-induced toxicity may be preventable through close attention to the mental status examination and judicious monitoring of plasma tricyclic levels during treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).